Prenatal diagnosis of steroid 21-hydroxylase deficiency by allele-specific amplification

Marily Theodoropoulou, Csaba Barta, Melinda Szoke, András Guttman, Maria Staub, Tamás Niederland, János Sólyom, György Fekete, Maria Sasvari-Szekely

Research output: Contribution to journalArticle

3 Citations (Scopus)


Objective: Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency (21-OHD) is the most common cause of ambiguous genitalia in females at birth. Here, we report the first prenatal diagnosis of 21-OHD by DNA analysis in Hungary. Methods: Allele-specific amplification (ASA) of the DNA obtained by chorionic villus sampling was performed. Results: The fetus had a homozygous nonsense mutation (Gln318Stop), suggesting a salt-wasting phenotype. Dexamethasone treatment of the mother was started on the 8th gestational week and, as the fetus was an affected female, it was continued until term. The newborn had normal external genitalia at birth, and severe salt-wasting crisis and postnatal virilization was prevented by mineralo- and glucocorticoid replacement therapy. Conclusion: 21-OHD was genotyped by ASA, and virilization of the fetus was prevented by antenatal dexamethasone therapy.

Original languageEnglish
Pages (from-to)237-240
Number of pages4
JournalFetal Diagnosis and Therapy
Issue number4
Publication statusPublished - Jul 9 2001


  • Allele-specific amplification
  • CYP21 gene
  • Genotyping
  • PCR
  • Prenatal diagnosis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Embryology
  • Radiology Nuclear Medicine and imaging
  • Obstetrics and Gynaecology

Fingerprint Dive into the research topics of 'Prenatal diagnosis of steroid 21-hydroxylase deficiency by allele-specific amplification'. Together they form a unique fingerprint.

  • Cite this